Diagnosis; Objective RespOnse; THErApy
Recruiting now · Not applicable
Conditions studied: Primary CNS Lymphoma
In brief
Thi is a prospective and low-intervention clinical trial. We propose to design a panel of "core" genetic alterations by sequencing Cerebral Spinal Fluid (CSF) DNA in patients with confirmed or suspicious Primary Central Neurvous System Lymphoma (PCNSL) with the aim to improve diagnostic sensitivity, response assessment and monitoring early CNS relapse in routine practice. Enrolled patients will receive conventional treatments according to well-established international guidelines, DNA assessments will not influence the treatment choices.
Key facts
- Study ID
- NCT05036564
- Run by
- IRCCS San Raffaele
- People needed
- 70
- Starts
- 2020-10-16
- Expected to finish
- 2027-04-30
- Last updated by the study team
- 2025-05-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- IRCCS Ospedale San Raffaele — Milan, Italy/Lombardy, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.